+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Soft Tissue Sarcoma: Competitive Landscape - Product Thumbnail Image

Soft Tissue Sarcoma: Competitive Landscape

  • Report
  • June 2024
  • 79 Pages
  • Global
From
From
Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • April 2024
  • 1332 Pages
  • Global
From
Colorectal Cancer - Eight-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Colorectal Cancer - Eight-Market Drug Forecast and Market Analysis

  • Report
  • December 2023
  • 146 Pages
  • Global
From
Hepatocellular Carcinoma - Global Clinical Trials Review, 2023 - Product Thumbnail Image

Hepatocellular Carcinoma - Global Clinical Trials Review, 2023

  • Clinical Trials
  • December 2023
  • 2557 Pages
  • Global
From
Glioblastoma Multiforme (GBM) - Competitive Landscape - Product Thumbnail Image

Glioblastoma Multiforme (GBM) - Competitive Landscape

  • Report
  • December 2023
  • 75 Pages
  • Global
From
Anal Cancer (AC) - Competitive Landscape - Product Thumbnail Image

Anal Cancer (AC) - Competitive Landscape

  • Report
  • December 2023
  • 77 Pages
  • Global
From
From
From
Multiple Myeloma Epidemiology Analysis and Forecast to 2032 - Product Thumbnail Image

Multiple Myeloma Epidemiology Analysis and Forecast to 2032

  • Report
  • November 2023
  • 47 Pages
  • Global
From
Antibody-Drug Conjugates (ADC): Market Overview - Product Thumbnail Image

Antibody-Drug Conjugates (ADC): Market Overview

  • Report
  • March 2024
  • 86 Pages
  • Global
From
Glioblastoma Multiforme (Gbm) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Glioblastoma Multiforme (Gbm) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • February 2024
  • 1378 Pages
  • Global
From
Ewing Sarcoma - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Ewing Sarcoma - Global Clinical Trials Review, 2024

  • Clinical Trials
  • February 2024
  • 294 Pages
  • Global
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more